Andrey Anatolyevich Khmelevsky

Oncologist, Urologist.

Medicine of the future is not only about technology but also a return to humanity: each patient is not just a case in a medical history but a person, and treatment is based not only on protocols but also on compassion, where prevention is more important than treatment, and research and empathy are equal.

About Me

I don’t just treat diseases; I help people regain health by considering their lifestyle, psychology, and personal circumstances. For me, it’s not only the diagnosis that matters but also the person behind it. My practice is based on evidence-based medicine, an individual approach, and honest care. I help you understand your body and achieve long-term health.

Professional interests:

• Innovative Methods of Organ-Preserving Treatment
• Immunotherapy and Targeted Therapy in Urological Oncology
• Diagnosis and Treatment of Erectile Dysfunction
• Male infertility
• Therapy to Increase Your Own Testosterone
• Therapy for Chronic Prostatitis and Chronic Pelvic Pain Syndrome
• Optimization of Antibacterial Therapy for Urinary Tract Infections

About me

• Sign up via MEDFLEX
• a.khmelevskii@buzaevclinic.ru

Education

Start	Completion	Studies
2005	2011	Bashkir State Medical University
2012	2012	Residency. Oncology
2012	2014	Residency. Oncology
2023	2023	PP. Urology
text ss

Advanced courses

Year	Study
2017	Bashkir State Medical University. Palliative Care in Oncology 144h.
2022	Bashkir State Medical University. Palliative Care in Oncology 144 hours
2020	Federal State Budgetary Institution National Medical Research Center of Radiology, Ministry of Health of Russia. Basics of Carcinogenesis and Laboratory Technologies for Screening, Diagnosis, Therapy Selection, and Tissue Defect Reconstruction in Cancer Patients. 36 hours.
2020	Federal State Budgetary Institution National Medical Research Center for Radiology of the Ministry of Health of Russia. Current Issues in Drug Treatment of Malignant Neoplasms
2020	FSBI NMITs of Radiology, Ministry of Health of Russia. Fundamentals of Carcinogenesis and Laboratory Technologies for Screening, Diagnosis, Therapy Selection, and Tissue Defect Reconstruction in Cancer Patients. 36 hours
2020	FSBI NMRRC of the Ministry of Health of Russia. Current Issues in Drug Treatment of Malignant Neoplasms
2022	Periodic Accreditation in Specialty “”Oncology “”
2024	Primary Specialized Accreditation in the Specialty “”Urology “”

Work Experience

2008 – 2010

Paramedic of the mobile team

EMS of Ufa

2012 – 2012

Oncologist

Clinic 46, Ufa

2012 – 2014

Oncologist

Polyclinic 52, Ufa

2014 – to the present time

Oncologist

GAUZ RKOD Ministry of Health RB

2025 – current time

Urologist Oncologist

V.S. Buzaev International Medical Centre

Research Publications

• LUNG CANCER / Gantsev Sh.Kh., Khmelevsky A.A. // Guide for Doctors, Moscow, 2020. –
• ASYMPTOMATIC KIDNEY TUMORS IN ELDERLY PATIENTS: REVIEW OF TREATMENT APPROACHES IN RUSSIA AND WESTERN COUNTRIES / Gantsev Sh.Kh., Gantsev K.Sh., Khmelevskiy A.A., Khrizman Y.N.//Advances in Gerontology.- 2020, T. 10  № 1. – S. 66-72
• ASYMPTOMATIC KIDNEY TUMORS IN ELDERLY PATIENTS: REVIEW OF TREATMENT APPROACHES IN RUSSIA AND WESTERN COUNTRIES / Gantsev Sh.Kh., Khmelevsky A.A., Gantsev K.Sh., Khrizman Yu.N. / / Advances in Gerontology. – 2019. – Vol. 32, No. 3. – P. 462-468
• USE OF BEVACIZUMAB + INTERFERON α-2A COMBINATION IN PATIENTS WITH DISSEMINATED KIDNEY CANCER COMPARED TO ACTIVE SURVEILLANCE GROUP / Creative Surgery and Oncology.- 2018, Vol. 8  ,№ 4. – S. 263-267.
• EFFECTIVENESS OF BEVACIZUMAB + INTERFERON α-2A IN PATIENTS WITH DISSEMINATED KIDNEY CANCER COMPARED TO THE ACTIVE SURVEILLANCE GROUP /Academic Journal of Western Siberia.- 2018, Vol. 14  № 5 (76). – S. 33-34
• EXPERIENCE OF LAPAROSCOPIC SURGERY IN THE TREATMENT OF RENAL CELL CARCINOMA AT THE REPUBLICAN CLINICAL ONCOLOGY DISPENSARY.- Khrizman Y.N., Gantsev K.Sh., Safiullin R.I., Khmelevsky A.A., Shakurov V.K., Aglamov R.I.- Creative Surgery and Oncology. 2017. Vol. 7  № 4